Exact Mass: 465.1913
Exact Mass Matches: 465.1913
Found 500 metabolites which its exact mass value is equals to given mass value 465.1913
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cisapride
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
cisapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
(E)-Squamosamide
(E)-Squamosamide is found in fruits. (E)-Squamosamide is isolated from branches of Annona squamosa (sugar apple). Isolated from branches of Annona squamosa (sugar apple). (E)-Squamosamide is found in fruits.
Biotripyrrin-a
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
Biotripyrrin-b
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
Acalabrutinib
Benzylpenicilloyl G
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA
Squamosamide
2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile
Ala Cys Ser Trp
Ala Cys Trp Ser
Ala Asp Phe Asn
Ala Asp Asn Phe
Ala Phe Asp Asn
Ala Phe Asn Asp
Ala Met Met Asn
Ala Met Asn Met
Ala Asn Asp Phe
Ala Asn Phe Asp
Ala Asn Met Met
Ala Ser Cys Trp
Ala Ser Trp Cys
Ala Trp Cys Ser
Ala Trp Ser Cys
Cys Ala Ser Trp
Cys Ala Trp Ser
Cys Cys Ile Lys
Cys Cys Ile Gln
Cys Cys Lys Ile
Cys Cys Lys Leu
Cys Cys Leu Lys
Cys Cys Leu Gln
Cys Cys Gln Ile
Cys Cys Gln Leu
Cys Asp Lys Thr
Cys Asp Thr Lys
Cys Glu Lys Ser
Cys Glu Ser Lys
Cys Gly Met Arg
Cys Gly Arg Met
Cys Gly Thr Trp
Cys Gly Trp Thr
Cys Ile Cys Lys
Cys Ile Cys Gln
Cys Ile Lys Cys
Cys Ile Gln Cys
Cys Lys Cys Ile
Cys Lys Cys Leu
Cys Lys Asp Thr
Cys Lys Glu Ser
Cys Lys Ile Cys
Cys Lys Leu Cys
Cys Lys Ser Glu
Cys Lys Thr Asp
Cys Leu Cys Lys
Cys Leu Cys Gln
Cys Leu Lys Cys
Cys Leu Gln Cys
Cys Met Gly Arg
Cys Met Asn Val
Cys Met Arg Gly
Cys Met Val Asn
Cys Asn Met Val
Cys Asn Val Met
Cys Gln Cys Ile
Cys Gln Cys Leu
Cys Gln Ile Cys
Cys Gln Leu Cys
Cys Arg Gly Met
Cys Arg Met Gly
Cys Arg Ser Thr
Cys Arg Thr Ser
Cys Ser Ala Trp
Cys Ser Glu Lys
Cys Ser Lys Glu
Cys Ser Arg Thr
Cys Ser Thr Arg
Cys Ser Trp Ala
Cys Thr Asp Lys
Cys Thr Gly Trp
Cys Thr Lys Asp
Cys Thr Arg Ser
Cys Thr Ser Arg
Cys Thr Trp Gly
Cys Val Met Asn
Cys Val Asn Met
Cys Trp Ala Ser
Cys Trp Gly Thr
Cys Trp Ser Ala
Cys Trp Thr Gly
Asp Ala Phe Asn
Asp Ala Asn Phe
Asp Cys Lys Thr
Asp Cys Thr Lys
Asp Phe Ala Asn
Asp Phe Gly Gln
Asp Phe Asn Ala
Asp Phe Gln Gly
Asp Gly Phe Gln
Asp Gly Gln Phe
Asp Lys Cys Thr
Asp Lys Thr Cys
Asp Asn Ala Phe
Asp Asn Phe Ala
Asp Gln Phe Gly
Asp Gln Gly Phe
Asp Thr Cys Lys
Asp Thr Lys Cys
Glu Cys Lys Ser
Glu Cys Ser Lys
Glu Phe Gly Asn
Glu Phe Asn Gly
Glu Gly Phe Asn
Glu Gly Asn Phe
Glu Lys Cys Ser
Glu Lys Ser Cys
Glu Asn Phe Gly
Glu Asn Gly Phe
Glu Ser Cys Lys
Glu Ser Lys Cys
Phe Ala Asp Asn
Phe Ala Asn Asp
Phe Asp Ala Asn
Phe Asp Gly Gln
Phe Asp Asn Ala
Phe Asp Gln Gly
Phe Glu Gly Asn
Phe Glu Asn Gly
Phe Gly Asp Gln
Phe Gly Glu Asn
Phe Gly Gly Trp
Phe Gly Asn Glu
Phe Gly Gln Asp
Phe Gly Trp Gly
Phe Asn Ala Asp
Phe Asn Asp Ala
Phe Asn Glu Gly
Phe Asn Gly Glu
Phe Gln Asp Gly
Phe Gln Gly Asp
Phe Trp Gly Gly
Gly Cys Met Arg
Gly Cys Arg Met
Gly Cys Thr Trp
Gly Cys Trp Thr
Gly Asp Phe Gln
Gly Asp Gln Phe
Gly Glu Phe Asn
Gly Glu Asn Phe
Gly Phe Asp Gln
Gly Phe Glu Asn
Gly Phe Gly Trp
Gly Phe Asn Glu
Gly Phe Gln Asp
Gly Phe Trp Gly
Gly Gly Phe Trp
Gly Gly Trp Phe
Gly Lys Met Met
Gly Met Cys Arg
Gly Met Lys Met
Gly Met Met Lys
Gly Met Met Gln
Gly Met Gln Met
Gly Met Arg Cys
Gly Asn Glu Phe
Gly Asn Phe Glu
Gly Gln Asp Phe
Gly Gln Phe Asp
Gly Gln Met Met
Gly Arg Cys Met
Gly Arg Met Cys
Gly Thr Cys Trp
Gly Thr Trp Cys
Gly Trp Phe Gly
Gly Trp Gly Phe
Ile Cys Cys Lys
Ile Cys Cys Gln
Ile Cys Lys Cys
Ile Cys Gln Cys
Ile Lys Cys Cys
Ile Gln Cys Cys
Lys Cys Cys Ile
Lys Cys Cys Leu
Lys Cys Asp Thr
Lys Cys Glu Ser
Lys Cys Ile Cys
Lys Cys Leu Cys
Lys Cys Ser Glu
Lys Cys Thr Asp
Lys Asp Cys Thr
Lys Asp Thr Cys
Lys Glu Cys Ser
Lys Glu Ser Cys
Lys Gly Met Met
Lys Ile Cys Cys
Lys Leu Cys Cys
Lys Met Gly Met
Lys Met Met Gly
Lys Ser Cys Glu
Lys Ser Glu Cys
Lys Thr Cys Asp
Lys Thr Asp Cys
Leu Cys Cys Lys
Leu Cys Cys Gln
Leu Cys Lys Cys
Leu Cys Gln Cys
Leu Lys Cys Cys
Leu Gln Cys Cys
Met Ala Met Asn
Met Ala Asn Met
Met Cys Gly Arg
Met Cys Asn Val
Met Cys Arg Gly
Met Cys Val Asn
Met Gly Cys Arg
Met Gly Lys Met
Met Gly Met Lys
Met Gly Met Gln
Met Gly Gln Met
Met Gly Arg Cys
Met Lys Gly Met
Met Lys Met Gly
Met Met Ala Asn
Met Met Gly Lys
Met Met Gly Gln
Met Met Lys Gly
Met Met Asn Ala
Met Met Gln Gly
Met Asn Ala Met
Met Asn Cys Val
Met Asn Met Ala
Met Asn Thr Thr
Met Asn Val Cys
Met Gln Gly Met
Met Gln Met Gly
Met Gln Ser Thr
Met Gln Thr Ser
Met Arg Cys Gly
Met Arg Gly Cys
Met Ser Gln Thr
Met Ser Thr Gln
Met Thr Asn Thr
Met Thr Gln Ser
Met Thr Ser Gln
Met Thr Thr Asn
Met Val Cys Asn
Met Val Asn Cys
Asn Ala Asp Phe
Asn Ala Phe Asp
Asn Ala Met Met
Asn Cys Met Val
Asn Cys Val Met
Asn Asp Ala Phe
Asn Asp Phe Ala
Asn Glu Phe Gly
Asn Glu Gly Phe
Asn Phe Ala Asp
Asn Phe Asp Ala
Asn Phe Glu Gly
Asn Phe Gly Glu
Asn Gly Glu Phe
Asn Gly Phe Glu
Asn Met Ala Met
Asn Met Cys Val
Asn Met Met Ala
Asn Met Thr Thr
Asn Met Val Cys
Asn Thr Met Thr
Asn Thr Thr Met
Asn Val Cys Met
Asn Val Met Cys
Gln Cys Cys Ile
Gln Cys Cys Leu
Gln Cys Ile Cys
Gln Cys Leu Cys
Gln Asp Phe Gly
Gln Asp Gly Phe
Gln Phe Asp Gly
Gln Phe Gly Asp
Gln Gly Asp Phe
Gln Gly Phe Asp
Gln Gly Met Met
Gln Ile Cys Cys
Gln Leu Cys Cys
Gln Met Gly Met
Gln Met Met Gly
Gln Met Ser Thr
Gln Met Thr Ser
Gln Ser Met Thr
Gln Ser Thr Met
Gln Thr Met Ser
Gln Thr Ser Met
Arg Cys Gly Met
Arg Cys Met Gly
Arg Cys Ser Thr
Arg Cys Thr Ser
Arg Gly Cys Met
Arg Gly Met Cys
Arg Met Cys Gly
Arg Met Gly Cys
Arg Ser Cys Thr
Arg Ser Thr Cys
Arg Thr Cys Ser
Arg Thr Ser Cys
Ser Cys Ala Trp
Ser Cys Glu Lys
Ser Cys Lys Glu
Ser Cys Arg Thr
Ser Cys Thr Arg
Ser Cys Trp Ala
Ser Glu Cys Lys
Ser Glu Lys Cys
Ser Lys Cys Glu
Ser Lys Glu Cys
Ser Met Gln Thr
Ser Met Thr Gln
Ser Gln Met Thr
Ser Gln Thr Met
Ser Arg Cys Thr
Ser Arg Thr Cys
Ser Ser Ser Trp
Ser Ser Trp Ser
Ser Thr Cys Arg
Ser Thr Met Gln
Ser Thr Gln Met
Ser Thr Arg Cys
Ser Trp Ala Cys
Ser Trp Cys Ala
Ser Trp Ser Ser
Thr Cys Asp Lys
Thr Cys Gly Trp
Thr Cys Lys Asp
Thr Cys Arg Ser
Thr Cys Ser Arg
Thr Cys Trp Gly
Thr Asp Cys Lys
Thr Asp Lys Cys
Thr Gly Cys Trp
Thr Lys Cys Asp
Thr Lys Asp Cys
Thr Met Asn Thr
Thr Met Gln Ser
Thr Met Ser Gln
Thr Met Thr Asn
Thr Asn Met Thr
Thr Asn Thr Met
Thr Gln Met Ser
Thr Gln Ser Met
Thr Arg Cys Ser
Thr Arg Ser Cys
Thr Ser Cys Arg
Thr Ser Met Gln
Thr Ser Gln Met
Thr Ser Arg Cys
Thr Thr Met Asn
Thr Thr Asn Met
Val Cys Met Asn
Val Cys Asn Met
Val Met Cys Asn
Val Met Asn Cys
Val Asn Cys Met
Val Asn Met Cys
Trp Phe Gly Gly
Trp Gly Phe Gly
Trp Gly Gly Phe
Trp Ser Ser Ser
Sulprostone
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D008600 - Menstruation-Inducing Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C78568 - Prostaglandin Analogue
Squamosamide
Sarpogrelate Hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Sarpogrelate hydrochloride (MCI-9042) is a selective 5-HT2R antagonist, with pKis of 8.52, 6.57, and 7.43 for 5-HT2A, 5-HT2B, and 5-HT2C receptors, respectively. Sarpogrelate hydrochloride displays selectivity over 5-HT1, 5-HT3, 5-HT4, α1-, α2- and β-adrenoreceptor, histamine H1, H2 and muscarinic M3 receptors. Sarpogrelate hydrochloride can be used for the research of vascular disease associated with thrombosis[1][2][3].
N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE
TERT-BUTYL 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE
Acalabrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE
Haloperidol Lactate
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
CID 24906286
Bevonium metilsulfate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
(2R)-1-(Dimethylamino)-3-{4-[(6-{[2-fluoro-5-(trifluoromethyl)phenyl]amino}pyrimidin-4-YL)amino]phenoxy}propan-2-OL
Tert-Butyl 4-({[4-(But-2-Yn-1-Ylamino)phenyl]sulfonyl}methyl)-4-[(Hydroxyamino)carbonyl]piperidine-1-Carboxylate
[[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-oxidophosphoryl] phosphate
(Z,Z)-2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-2,5-dihydro-4-methyl-5-oxo-1H-Pyrrole-3-propanoate
Brasiliquinone A
A carbopolycyclic compound that is (3S)-3-ethyl-6,8-dihydroxy-3,4-dihydrotetraphene-1,7,12(2H)-trione substituted at position 8 by a 3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl group. It is isolated from the culture broth of Nocardia brasiliensis and exhibits antibacterial activity against Gram-positive bacteria. It is also active against the multiple drug-resistant P388/ADR tumour cells.
N-[2-(tert-butylamino)-2-oxo-1-thiophen-2-ylethyl]-N-(2-oxolanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide
5-[[2-[4-[1-(1,3-Dioxo-2-indenylidene)ethyl]-1-piperazinyl]ethylamino]methylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide
(2E)-5-[(1S,2S,4aR,8aR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
[(1S)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
[(1R)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
1-[2-[(2R,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
1-[2-[(2S,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
Propulsid
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].